Background: The Bentall procedure remains a cornerstone operation for combined aortic root and valve pathology despite increasing adoption of valve-sparing techniques. Methods: This retrospective single-center study analyzed 15 consecutive Bentall procedures performed between 2014 and 2024. Demographic variables, indications, operative parameters, early outcomes, and mid-term follow-up results were evaluated. Results: Mean age was 53.1 ± 12.8 years, with male predominance (80%). Aortic root aneurysm with severe aortic regurgitation was the most common indication (53%). Mechanical composite grafts were used in 67% of patients. Thirty-day mortality was 6.7%. At a mean follow-up of 4.6 ± 2.4 years, overall survival was 93% with no reoperations. Conclusion: The Bentall procedure continues to provide excellent early and mid-term outcomes and remains a reliable option for complex aortic root disease.
Since its original description by Bentall and De Bono in 1968 [1], composite aortic root replacement has become the standard surgical treatment for patients with combined aortic valve and ascending aortic pathology. Advances in surgical technique, myocardial protection, and prosthetic valve technology have significantly improved outcomes over the past decades [2,3].
Current ACC/AHA and ESC guidelines recommend aortic root replacement in patients with aortic root aneurysm associated with significant valve disease, connective tissue disorders, and selected cases of acute type A aortic dissection [6,7]. Although valve-sparing root replacement has gained popularity in selected patients, the Bentall procedure remains widely practiced due to its reproducibility and applicability in patients with severe valve pathology, infective endocarditis, and emergency presentations [4,8].
This retrospective single-center observational study included all adult patients who underwent Bentall procedures between January 2014 and December 2024. Institutional ethics committee approval was obtained, and the requirement for individual informed consent was waived owing to the retrospective nature of the study. Patient demographics, comorbidities, imaging findings, operative details, perioperative complications, and follow-up outcomes were extracted from hospital records and surgical databases. Surgical Technique All procedures were performed via median sternotomy under general anesthesia. Standard aortic and right atrial cannulation was employed in elective cases without arch involvement. In patients with extensive ascending aortic pathology, anticipated circulatory arrest, or acute type A aortic dissection, an extra-anatomic cerebral perfusion strategy was routinely utilized. A 6–8 mm ringed polytetrafluoroethylene (PTFE) graft was anastomosed end-to-side to the right subclavian artery through an infraclavicular incision. The graft was cannulated and connected to the arterial limb of the cardiopulmonary bypass circuit, allowing continuous antegrade cerebral perfusion during cooling, hypothermic circulatory arrest when required, and rewarming [9–11]. Systemic cooling to moderate hypothermia (24–28°C) was used when circulatory arrest was required. Myocardial protection was achieved using cold blood cardioplegia administered via antegrade and retrograde routes. The diseased aortic root and valve were excised, a composite valved conduit was implanted at the level of the aortic annulus, coronary buttons were reimplanted, and distal graft anastomosis was completed following re-establishment of systemic perfusion. Fig 1 and 2: –8 mm ringed polytetrafluoroethylene (PTFE) graft anastomosed end-to-side to the right subclavian artery through an infraclavicular incision Fig 3 and 4: Aortic root and ascending aorta aneurysm with aortic valce exposed after opening aneurysmal segment Fig 5 and 6: Ethibond sutures taken on the valve and Bentall’s conduit being lowered into the valve Fig 7: Bentall’s conduit sutured to the aortic valve
|
|
Value |
|
Age (years) |
53.1 ± 12.8 |
|
Male sex |
12 (80%) |
|
Hypertension |
10 (67%) |
|
Diabetes mellitus |
4 (27%) |
|
Bicuspid aortic valve |
4 (27%) |
|
Marfan syndrome |
2 (13%) |
|
Indication |
Number (%) |
|
Aortic root aneurysm with severe AR |
8 (53%) |
|
Bicuspid valve with root dilation |
4 (27%) |
|
Acute type A aortic dissection |
2 (13%) |
|
Infective endocarditis with root abscess |
1 (7%) |
|
Parameter |
Value |
|
CPB time (min) |
168 ± 30 |
|
Cross-clamp time (min) |
121 ± 24 |
|
Mechanical composite graft |
10 (67%) |
|
Bioprosthetic composite graft |
5 (33%) |
|
30-day mortality |
1 (6.7%) |
|
Stroke |
1 (6.7%) |
|
Re-exploration for bleeding |
1 (6.7%) |
The Bentall procedure remains a safe, effective, and durable solution for complex aortic root pathology. With meticulous surgical technique and modern cerebral protection strategies, excellent early and mid-term outcomes can be achieved.